MedTech VP
VP Commercial, MedTech scale-up
+180%
post engagement rate
90 days
Illustrative
Healthcare & MedTech
LinkedIn Ghostwriting for Healthcare and MedTech Executives
LinkedIn ghostwriting for healthcare executives has two hard lines: no identifiable patient, and no product claim outside your cleared or approved labelling. Everything else is open, and most of it is unwritten. We build pillars around care delivery, evidence and how health systems actually buy, then route anything product-specific through your regulatory and medical reviewers.
- A patient-privacy rule set agreed before the first draft
- Separate tracks for disease-state content and product claims
- Posts written for value-analysis committees, not for conference crowds
Book your free audit call30 min · Free · No pitch deck
You approve every post, and your reviewers see anything that touches a claim.
Or start with the free LinkedIn profile audit
From $1,500/month. Compare plans
Could be anyone
We lost our best engineer because I scheduled standup for 7am.
She told me in the exit interview. Not the pay. Not the roadmap. The standup. She had a school drop-off at 7.40 and she'd spent five months quietly failing at both jobs rather than ask me to move a meeting.
I'd copied the 7am standup from a blog post about high-performing teams.
We moved it to 10. Nobody has left since.
Most of what you call culture is a list of things you copied from someone else and never questioned.
Last updated: 5 October 2026
Founders and executives in
- B2B SaaS
- Fintech
- Healthcare & MedTech
- Legal
- Consulting
- Real estate
- Manufacturing
- Hospitality
What buyers say · market research
- of B2B decision-makers trust thought leadership more than marketing materials to judge a company's capabilities
- 73%1
- of decision-makers are more receptive to outreach from a company that consistently publishes high-quality thought leadership
- 90%1
- of decision-makers say good thought leadership makes them willing to pay a premium
- 60%1
How health systems decide, and who you’re really writing for
Almost nobody writes for the people who actually approve a purchase in healthcare, which is why this is the easiest advantage in the sector to take.
A clinician champions a device or a platform. A value-analysis or new-technology committee then weighs it against contract compliance, existing standardisation agreements, supply chain impact, training burden and total cost. Finance looks at the coding and coverage question: whether the thing can be paid for, not whether it works. Infection prevention, biomedical engineering and IT security each have a veto. The timeline is measured in quarters.
So there are four readers of a healthcare executive’s feed. The clinical champion, who wants to know you understand their workflow. The administrator, who wants the operational and financial case. The payer-facing reader, who wants the reimbursement path. And the talent market, which is where the content quietly pays for itself, because clinicians moving into industry research the leadership before they apply.
A fifth group reads too: your own regulatory affairs team, and sometimes a regulator. Write as though they do.
Content pillars for a healthcare or MedTech executive
Eight angles that don’t require a patient story or a product claim.
1. The system problem you’ve measured. Throughput, length of stay, prior authorisation turnaround, the handoff that drops information. Written from operating data you’re allowed to share, with the method stated.
2. What the evidence actually says. Walk through a published trial or registry analysis, including its limitations and what it doesn’t support. Link the source. Honest reading of evidence is rare enough on LinkedIn that it functions as a differentiator.
3. How your buyer actually buys. A plain account of a value-analysis committee: who sits on it, what it asks, which submissions fail and why. The most useful post a MedTech leader can publish, and almost nobody does.
4. Clinician workflow reality. The eleven clicks, the night shift, the documentation burden, what a nurse does when the system is down. Credible only from someone who has watched it.
5. After go-live. Implementation, training, the adoption curve that flattened, change management that worked. Clearance is not adoption, and saying so publicly builds trust with administrators.
6. Coding, coverage and reimbursement. The gap between a device being approved and a device being paid for. Technical, dry, and forwarded to exactly the people you want.
7. The workforce. Hiring clinicians into industry, retention, burnout, scope of practice. Say the unpopular thing if you hold the view.
8. Composite stories, labelled as composites. Where a human account is the only way to make a point, we write a composite assembled from several situations and label it as one. Real patient stories only exist on the page with documented written authorisation, and usually not even then.
Book your free audit call30 min · Free · No pitch deck
How LinkedIn ghostwriting for healthcare executives works around privacy and regulatory review
Which rules bind you depends on your entity type, your products and your jurisdictions. We ask rather than assume, and your regulatory, medical and privacy functions decide. The concerns that shape the work:
Patient privacy is stricter than people expect. If your organisation handles protected health information as a covered entity or business associate, using patient information in marketing generally requires written authorisation, and de-identification is a defined standard rather than “I took the name out”. A photograph, a condition, a timeframe and a city can re-identify someone between them. Our default is that patients do not appear in content at all.
Product claims are regulated promotion. For a device, diagnostic or therapeutic, a public statement about what your product does is promotional material, and it needs to be consistent with what has been cleared or approved. Describing an intended use that hasn’t been cleared, or promoting an investigational product as though it’s available, is the most common and most expensive mistake a founder makes in this sector. It’s also the most natural thing in the world to do in an enthusiastic post, which is exactly why claims go through your reviewers and not through us.
Healthcare professional relationships are governed. Industry codes and transparency rules shape how companies may interact with clinicians. A warm post thanking a named physician, or anything that reads as an endorsement arrangement, is a question for your compliance team before it’s a question of tone.
Clinician-executives carry their own obligations. If you’re licensed, your board’s rules on professional conduct and advertising follow you onto LinkedIn, and a reply in a comment thread can look like individual clinical advice. We write the general case and avoid the specific one.
The review model. Disease-state, system-level and workforce content runs on a standard track with your approval. Anything touching product performance, comparative claims, indications or clinical outcomes goes to medical, regulatory and legal review before it reaches your queue, with the claim highlighted and the source attached. If a reviewer says no, the post dies.
“One post could become a privacy incident”
It could, and that fear is the reason most healthcare executives publish nothing for years, which has its own cost: the clinical hires you don’t get and the committees that have never heard of you.
The practical answer is a boundary document, written in week one and signed off by your privacy and regulatory people. It lists what never appears: patients, identifiable sites, named clinicians without written consent, unpublished study data, anything about a live regulatory submission, images from clinical environments, and claims outside labelling. It also lists what does: your own operating data at an aggregate level, published literature, system-level argument, and your reasoning as an operator.
Writers work inside that document rather than guessing. The interview transcript is treated as confidential material, stored under your retention rules rather than ours if your counsel requires it. And because nothing publishes without your approval, the worst case is a draft you kill, not a post you have to explain.
Roles we write for in healthcare
- Founder or CEO of a MedTech, diagnostics or health-tech company — the system argument and the buying-committee content
- Chief Medical Officer — evidence reading and clinical workflow, with the heaviest review load
- Chief Nursing or Operations Officer — throughput, staffing and implementation reality
- Health system or hospital group executive — care model, workforce and capital decisions
A whole leadership team posting together is handled as a programme. See corporate personal branding, and note that an executive’s profile does most of the work here, which is why executive LinkedIn profile optimization usually comes first.
Proof
We won’t claim clinical or sector experience we don’t have, and we won’t pass an anonymised sample off as a real healthcare client. What we can show on the call: a boundary document, a reviewer-ready draft with its claim flagged, and a monthly report. The case studies hub holds anything cleared for publication.
Items marked Sample are anonymised, illustrative examples written to typical industry ranges. They are not client results.
Services healthcare executives use most
LinkedIn ghostwriting agency →
Voice capture, voice guide, cadence and approvals in full.
LinkedIn personal branding agency →
The positioning work that decides which pillars you own.
Executive LinkedIn profile optimization →
The profile a value-analysis committee member reads before your meeting.
Related sectors: LinkedIn ghostwriting for lawyers and LinkedIn ghostwriting for fintech founders, both of which run on review workflows like yours. All ten are on the industries hub.
What it costs
The three published packages apply, from $1,500 a month. Most regulated healthcare clients need The Authority at $3,500, because the review cycle means we hold more approved content in reserve than an unregulated account would.
3-month minimum, then month to month with 30 days' notice. Prices exclude VAT (5% for UAE-based clients).
Compare what’s in each package
Book your free audit call30 min · Free · No pitch deck
Healthcare and MedTech LinkedIn FAQs
Our default is no. A real patient story needs documented written authorisation, and even then a condition plus a location plus a timeframe can identify someone. Where a human account is genuinely the only way to make the point, we write a composite from several situations and label it visibly as a composite. We never present a composite as a specific person.
Not everything. System-level, workforce and evidence-reading content runs on your own approval. Anything that touches product performance, indications, comparisons or clinical outcomes goes to medical, regulatory and legal review first, with the claim highlighted and the source attached so the review is quick.
You can talk about the problem, the science and the process of building a company. You cannot promote an investigational product or an uncleared use as though it’s available. This is the line founders cross most often by accident, so pre-launch accounts get a stricter boundary document and a named reviewer on every draft.
Published literature in your area, your instructions for use or product documentation, your own recorded talks, and 30 minutes with your medical affairs or clinical lead. We build a glossary you correct. We don’t pretend to clinical judgement, and we never write a clinical claim that didn’t come from you or from a source we can cite.
Yes. Your licensing board’s conduct and advertising rules follow you onto LinkedIn, and a reply in a comment thread can look like individual advice to a patient. We keep content at the general and system level, and we route anything that could be read as personal clinical guidance back to you with that flagged.
Reach first, then engagement from clinical and administrative titles at target systems, then profile views and search appearances from the committee seats you care about, then inbound: speaking invitations, partnership conversations, clinical hires and meetings. We separate recruiting outcomes from commercial ones, because in this sector the hiring value often arrives first.
Still have a question? Email us, or book your free audit call.
Thirty minutes, and bring whoever owns review
The most productive version of this call includes your regulatory, medical or privacy lead. We’ll draw the boundary document live and tell you which pillars are realistically open to you.
We read your market and your published evidence first
You do most of the talking
You leave with a boundary document, or a straight no
Book your free audit call30 min · Free · No pitch deck
hello@thoughtleaders.aeWe reply within one working dayMon–Fri, 9:00–18:00 GST
You approve every post, and your reviewers see anything that touches a claim.